The immune response to Aspergillus antigens in ABPA patients, as well as allergic asthmatic and CF patients, is characterized by a Th2 CD4+ T lymphocyte response [17, 31–35]. The gene discussed is CD4; the disease is allergic bronchopulmonary aspergillosis.